GENINCODE PLC LS -01 Asset Resilience Ratio

Latest as of December 2025: 2.86%

GENINCODE PLC LS -01 asset resilience ratio. GENINCODE PLC LS -01 (9PL) has an Asset Resilience Ratio of 2.86% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 9PL days of operational coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

€68.00K

≈ $79.50K USD Cash + Short-term Investments

Total Assets

€2.38 Million

≈ $2.78 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of GENINCODE PLC LS -01 (2021–2025)

Asset resilience ratio of GENINCODE PLC LS -01 from 2021 to 2025. This chart shows how GENINCODE PLC LS -01's Asset Resilience Ratio has changed over time. Read GENINCODE PLC LS -01 debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down GENINCODE PLC LS -01's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see GENINCODE PLC LS -01 (9PL) total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€68.00K	2.86%
Total Liquid Assets	€68.00K	2.86%

Asset Resilience Insights

Limited Liquidity: GENINCODE PLC LS -01 maintains only 2.86% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

GENINCODE PLC LS -01 Industry Peers by Asset Resilience Ratio

Compare GENINCODE PLC LS -01's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Lonza Group AG SW:LONN	Diagnostics & Research	3.04%
Revvity Inc. NYSE:RVTY	Diagnostics & Research	0.00%
Dr. Lal Path Labs Ltd. NSE:LALPATHLAB	Diagnostics & Research	13.43%
Guangzhou Kingmed Diagnostics Group Co Ltd SHG:603882	Diagnostics & Research	0.14%
Cowealth Medical China Co.Ltd. SHG:603122	Diagnostics & Research	2.25%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%
Prodia Widyahusada Tbk PT JK:PRDA	Diagnostics & Research	7.82%
Scope Fluidics SA WAR:SCP	Diagnostics & Research	16.51%

GENINCODE PLC LS -01 Asset Resilience Ratio by Year (2021–2025)

GENINCODE PLC LS -01 asset resilience ratio by year from 2021 to 2025. The table below shows the annual Asset Resilience Ratio data for GENINCODE PLC LS -01.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	2.86%	€68.00K ≈ $79.50K	€2.38 Million ≈ $2.78 Million	+0.80pp
2024-12-31	2.07%	€55.00K ≈ $64.30K	€2.66 Million ≈ $3.11 Million	+1.06pp
2023-12-31	1.00%	€42.00K ≈ $49.10K	€4.19 Million ≈ $4.89 Million	+0.87pp
2022-12-31	0.14%	€16.00K ≈ $18.71K	€11.80 Million ≈ $13.79 Million	+0.11pp
2021-12-31	0.03%	€4.00K ≈ $4.68K	€15.21 Million ≈ $17.78 Million	--

pp = percentage points

About GENINCODE PLC LS -01

F:9PL Germany Diagnostics & Research

Market Cap

$5.28 Million

€4.52 Million EUR

Market Cap Rank

#28396 Global

#2446 in Germany

Share Price

€0.01

Change (1 day)

+0.00%

52-Week Range

€0.00 - €0.08

All Time High

€0.45